fC6MQX

Poster Presentations – Sunday, October 19, 3:30 pm - 7:00 pmP241. Homeostasis of Iron and Hepcidin in Erythropoietic Protoporphyriaand X-Linked ProtoporphyriaKrista Bossi, MS, Jingyun Lee, PhD, Paul Schmeltzer, MD, GaleGroseclose, RN, Siddesh Besur, MD, Sunil Hwang, PhD, HerbertBonkovsky, MD, FACG, Carolinas Medical Center, Charlotte, NCP242. A Novel Method for Measuring Skeletal Muscle Mass in LiverCirrhosis Using Adobe PhotoshopPavan Mankal, MD, MA, Priya Simoes, MD, MBBS, Ahmad Hakimzada,MD, Imad Asaad, MD, Adel Asaad, MD, Donald Kotler, MD, FACG,Department of Medicine, Mount Sinai St. Lukes Roosevelt HospitalCenter, New York, NYP243. Logistic Issues in the Treatment of HCV Patients With the New AllOral DAA AgentsKenda Al-Assi, Farhan Arif, MD, Melissa Horton, BS, Deborah Baker,LVN, Cheryl Levine, PhD, Dana Al-Assi, Reem Ghalib, MD, TexasClinical Research Institute, Arlington, TX, Texas Digestive DiseaseConsultants, Arliington, TX, Texas Health Physician Group, Arlington, TXP244. Sofosbuvir Based Therapy for Hepatitis C After LiverTransplantationAlexander Weick, MD, Khalid George, MD, Syed-Mohammed Jafri, MD,Dilip Moonka, MD, Henry Ford Hospital, Detroit, MIP245. Endoscopic Cyanoacrylate Is a Useful Therapy in Gastric Varicesbut Early Rebleed Can Be a ThreatShahid Karim, MD, MACG, Wasim Jafri, MD, FACG, Afsheen Faryal,MD, Mohammad Arsalan Siddiqui, MD, Adil Memon, MD, RabeeaMirza, MD, Samrah Zaigham, MD, Saeed Hamid, MD, FACG, LiaquateNational Hospital and Medical College, Karachi, Pakistan, Agha KhanUnivercity Hospital, Karachi, PakistanP246. Non-Alcoholic Steatohepatitis: Role of Inflammation and OxidativeStressCharoen Mankongpaisarnrung, MD, Sangyi Park, MS, Jan Simoni,PharmD, Sharma Prabhakar, MD, Texas Tech University HealthSciences Center (TTUHSC), Lubbock, TXP247. Movement Disorders in Hereditary Hemochromatosis: Case SeriesKarthik Ragunathan, MD, Arthi Vamsi, MBBS, Sonu Dhillon, MD,University of Illinois College of Medicine, Peoria, Peoria, IL, OSF St.Francis Medical Center, Peoria, ILP248. Results of Simeprevir and Sofosbuvir Combination Therapy inHCV Genotype 1 Patients Who Have Failed Prior DAA: A Clinical PracticeExperienceDana Al-Assi, Farhan Arif, MD, Melissa Horton, BS, Deborah Baker,LVN, Cheryl Levine, PhD, Kenda Al-Assi, Reem Ghalib, MD, TexasClinical Research Institute, Arlington, TX, Texas Digestive DiseaseConsultants, Arlington, TX, Texas Health Physician Group, Arlington, TXP249. Vitamin D Levels Are Not Correlated With Hepatitis C RNA LevelsSumeet Munjal, MD, Jeong-hee Ku, MD, Cheng Cheng, MD, SandhyaShukla, MD, Rositsa Dimova, PhD, Jeena Yoo, MD, Craig Keller, MD,Sunkanmi Ajewole, MD, Thomas Mahl, MD, Department of Medicine,University at Buffalo and VA Western New York, Buffalo, Buffalo, NY,Department of Biostatistics, University at Buffalo, Buffalo, NYP250. Zieve’s Syndrome: Autoimmune Hemolytic Anemia AssociatedWith Alcoholic Liver Disease and HyperlipidemiaCrystale Cruz, MS, DO, John Bassett, MD, FACG, Dawn Torres, MD,FACG, Walter Reed National Military Medical Center, Bethesda, MDP251. Caroli’s Disease: An Unusual PresentationJoseph Salhab, DO, Saras Sharma, DO, Farhan Israr, DO, MichaelValladares, DO, Javier Sobrado, MD, Larkin Community Hospital,Miami, FLP252. Real Life Experience of Hepatitis C Treatment With a Combinationof Sofosbuvir and SimeprevirTavankit Singh, MD, Gurshawn Singh, MD, Mina Shaker, MD, IbrahimHanouneh, MD, Nizar Zein, MD, Naim Alkhouri, MD, Cleveland ClinicFoundation, Cleveland, OHP253. Salvage Plasmapheresis for Small-for-Size Syndrome FollowingHepatic Resection for Hepatocellular CarcinomaCynthia Quainoo, MD, Cynthia Victor, DO, Ayse Aytaman, MD, FACG,GI, SUNY Downstate, Brooklyn, NY, VA NY Harbor Health Care System,Brooklyn, NYP254. The Impact of Peri-Discharge Interventions on 30-dayReadmission and 90-day Mortality Rates for Patients Admitted WithHepatic EncephalopathyRoland Li, MD, Ann Tierney, MS, Rotonya Carr, MD, Department ofMedicine, University of Pennsylvania, Philadelphia, PA, Department ofBiostatistics and Epidemiology, University of Pennsylvania, Philadelphia,PA, Gastroenterology, University of Pennsylvania, Philadelphia, PAP255. Birth Cohort Screening for Hepatitis C: A Comparative Analysis inForeign-born Versus U.S.-born Baby Boomers2014 ACG Presidential Poster AwardKenechukwu Chudy-Onwugaje, MD, MPH, Stanley Yakubov, MD,Jack Husney, MD, Daniel Benasher, MD, Chukwudi Obiagwu, MD,Steven Shamah, MD, Kelly Teagle, DO, Amala Talasila, MD, Ira Mayer,MD, FACG, Yuriy Tsirlin, MD, FACG, James Park, MD, FACG, RabinRahmani, MD, FACG, Maimonides Medical Center, Brooklyn, NY,Department of Gastroenterology, New York University, New York, NYP256. Predictors of Mortality in Cirrhotic Inpatients With C. difficileInfectionElliot Smith, MD, Patrick Northup, MD, Curtis Argo, MD, MS, Universityof Virginia Health System, Charlottesville, VAP257. Treatment of Chronic HCV With Sofosbuvir (SOF) and Simeprevir(SMV) in Patients With Cirrhosis and Contraindications to Peginterferon(PEGINF) and Ribavirin (RBV)Mitchell Shiffman, MD, FACG, Amy James, NP, April Long, NP, PhilipAlexander, NP, Liver Institute of Virginia, Bon Secours Health System,Richmond, VA, Liver Instiutute of Virgnia, Bon Secours Health System,Newport News, VAP258. Safety Comparison of 12- and 24-Week Treatments inHCVGenotype 1-Infected Patients With Cirrhosis: Results From Turquoise-IINancy Reau, MD, Paul Kwo, MD, Michael Bennett, MD, HeinerWedemeyer, MD, Xavier Forns, MD, PhD, Antonio Craxi, MD, StefanBourgeois, MD, Stephen Ryder, MD, Dominique Larrey, MD, DavidMutimer, MD, Sandra Lovell, PhD, Manal Abunimeh, BSN, MarcosPedrosa, MD, PhD, Roger Trinh, MD, MPH, University of ChicagoMedical Center, Chicago, IL, Indiana University, Indianapolis, IN,Medical Associates Research Group, San Diego, CA, MedizinischeHochschule Hannover, Hannover, Germany, Liver Unit, HospitalClinic, IDIBAPS, CIBEREHD, Barcelona, Spain, A.O.U Policlinico “P.Giaccone” Dip. Di Gastroenterologia ed Epatologia D.B.M.I.S., Palermo,Italy, ZNA Stuivenberg, Antwerpen, Belgium, Nottingham DigestiveDiseases Centre and Biomedical Research Unit, Nottingham, UnitedKingdom, CHU de Montpellier, Hopital Saint Eloi, Montpellier, France,Queen Elizabeth Hospital and NIHR Liver Biomedical Research Unit,Birmingham, United Kingdom, AbbVie, Inc., North Chicago, ILP259. Chronic Narcotic Use Before and After Liver TransplantationIncreases Three Year Mortality and Has Deleterious Effects on the Rate ofRejection, Rehospitalization and One Year MortalityMina Pirzadeh, MD, Amir Prushani, MD, Allen Yudovich, MD, Syed-Mohammed Jafri, MD, Internal Medicine, Boston Medical Center,Boston, MA, Henry Ford Hospital, Detroit, MIP260. Early Kidney Dysfunction After Liver Transplantation Is AssociatedWith Reduced Graft and Patient SurvivalRahima Bhanji, MD, Mang Ma, MD, Vincent Bain, MD, Aldo Montano-Loza, MD, MSc, PhD, Gastroenterology and Liver Unit, University ofAlberta, Edmonton, AB, CanadaP261. Resuscitation Strategies for Cirrhotic Patients With Septic ShockKevin Davidson, MD, Carlos Girod, MD, University of TexasSouthwestern, Dallas, TXP262. Plasma Transfusion in Cirrhotic Patients Undergoing Hernia RepairJustin Hartke, MD, Claire Meyer, MD, Stephen Caldwell, MD, NeeralShah, MD, University of Virginia, Department of Gastroenterology,Charlottesville, VA, Washington University, St. Louis, MOP263. Alpha-1 Antitrypsin Deficiency and the Risk of HepatocellularCarcinoma in Patients With End-Stage Liver DiseaseClara Antoury, MD, Rocio Lopez, MS, MPH, Nizar Zein, MD, JamesStoller, MD, Naim Alkhouri, MD, Cleveland Clinic, Cleveland, OHFor more information on ACG 2014 and to register, visit www.acgmeetings.gi.org.50